Crescendo Health nabbed $3.4 million in seed funding to bring innovation into medical research by unlocking traditionally siloed health data. The San Francisco-based startup built a real-world data ...
With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...
AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced the results of its DEFINE-HT clinical trial in heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback